首页> 外文期刊>Dental Journal: Majalah Kedokteran Gigi >Potency of Stichopus hermanii extract as oral candidiasis treatment on epithelial rat tongue
【24h】

Potency of Stichopus hermanii extract as oral candidiasis treatment on epithelial rat tongue

机译:人参提取物作为口腔念珠菌病治疗上皮大鼠舌的功效

获取原文
           

摘要

Background: Oral candidiasis is the most prominent oral fungal infection with Candida albicans (C. albicans) as 75% of ethiologic factor. Golden sea cucumbers (Stichopus hermanii) have been consumed by Asian community as folk medicine. It has been known to have antifungal and immunomodulator agent thus potential to be explored as treatment in oral candidiasis. Purpose: The aim of this study was to examine the potency of Stichopus hermanii extract as oral candidiasis treatment. Method: The study was an experimental laboratories research with post test only control group design. Thirty male wistar rats were divided into 5 groups i.e negative control, positive control and 3 treatment groups. Oral candidiasis condition were induced by spraying C. albicans suspension on dorsal tongue of wistar rats, once in 2 days for 14 days. The treatment groups were given Stichopus hermanii extract on the dose of 4.25 ml/kgBW, 8.5 ml/kgBW, 17 ml/kgBW once daily for 14 days. The expression of anti C. albicans antibody and TNF-α were examined by immunohistochemistry on ephitelial tongue. Data was analyzed by Manova and LSD test. Result: Anti C. albicans antibody expression were higher in positive control group than in negative control group while TNF-α expression were lower in positive control group than in negative control group (p<0.05). Treatment with Stichopus hermanii extract on all doses decreased the expression of anti C. albicans antibody and increased the expression of TNF-α (p<0.05). Conclusion: Stichopus hermanii extract decreased the expression of anti C. albicans antibody and increased the expression of TNF-α in epithelial rat tongue.
机译:背景:口腔念珠菌病是最严重的口腔真菌感染,白色念珠菌(C. albicans)占埃希托病因子的75%。亚洲社区已将金海参(Stichopus hermanii)用作民间药物。已知具有抗真菌剂和免疫调节剂,因此有潜力作为口腔念珠菌病的治疗方法。目的:本研究的目的是检查曼氏刺桐提取物作为口服念珠菌病治疗的效力。方法:该研究是一个实验实验室研究,仅具有测试后对照组。将三十只雄性Wistar大鼠分为5组,即阴性对照组,阳性对照组和3个治疗组。通过将白色念珠菌悬液喷洒在wistar大鼠的背舌上诱导口腔念珠菌病,每2天一次,持续14天。给治疗组每日一次分别以4.25 ml / kgBW,8.5 ml / kgBW,17 ml / kgBW的剂量给予人参刺花提取物。通过免疫组织化学方法在上phi舌上检测抗白色念珠菌抗体和TNF-α的表达。通过Manova和LSD测试分析数据。结果:阳性对照组的抗白色念珠菌抗体表达高于阴性对照组,而阳性对照组的TNF-α表达低于阴性对照组(p <0.05)。在所有剂量下,用曼氏虎杖提取物处理均降低了白色念珠菌抗体的表达,并增加了TNF-α的表达(p <0.05)。结论:刺参提取物可降低上皮大鼠舌上抗白色念珠菌抗体的表达,并增加TNF-α的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号